A detailed history of Black Rock Inc. transactions in Singular Genomics Systems, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 738,711 shares of OMIC stock, worth $265,935. This represents 0.0% of its overall portfolio holdings.

Number of Shares
738,711
Previous 833,595 11.38%
Holding current value
$265,935
Previous $383,000 1.83%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$0.4 - $0.61 $37,953 - $57,879
-94,884 Reduced 11.38%
738,711 $376,000
Q4 2023

Feb 13, 2024

SELL
$0.33 - $0.58 $10,722 - $18,844
-32,491 Reduced 3.75%
833,595 $383,000
Q3 2023

Nov 13, 2023

SELL
$0.37 - $0.99 $2,667 - $7,137
-7,210 Reduced 0.83%
866,086 $329,000
Q2 2023

Aug 11, 2023

SELL
$0.78 - $1.28 $2.03 Million - $3.33 Million
-2,603,058 Reduced 74.88%
873,296 $724,000
Q1 2023

May 12, 2023

SELL
$1.1 - $2.95 $86,203 - $231,182
-78,367 Reduced 2.2%
3,476,354 $4.21 Million
Q4 2022

Feb 13, 2023

SELL
$1.82 - $2.71 $350,191 - $521,439
-192,413 Reduced 5.13%
3,554,721 $7.14 Million
Q3 2022

Nov 14, 2022

BUY
$2.5 - $4.73 $777,695 - $1.47 Million
311,078 Added 9.05%
3,747,134 $9.37 Million
Q2 2022

Aug 12, 2022

BUY
$2.86 - $6.44 $1.73 Million - $3.9 Million
605,379 Added 21.39%
3,436,056 $13.1 Million
Q1 2022

May 12, 2022

BUY
$5.94 - $12.09 $10.1 Million - $20.6 Million
1,700,829 Added 150.54%
2,830,677 $17.9 Million
Q4 2021

Feb 10, 2022

BUY
$10.45 - $16.9 $5.13 Million - $8.29 Million
490,781 Added 76.8%
1,129,848 $13.1 Million
Q3 2021

Nov 09, 2021

BUY
$10.9 - $27.63 $6.25 Million - $15.8 Million
573,205 Added 870.31%
639,067 $7.15 Million
Q2 2021

Aug 11, 2021

BUY
$23.16 - $31.17 $1.53 Million - $2.05 Million
65,862 New
65,862 $1.81 Million

Others Institutions Holding OMIC

About Singular Genomics Systems, Inc.


  • Ticker OMIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 71,193,296
  • Market Cap $25.6M
  • Description
  • Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associat...
More about OMIC
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.